Innovation Intelligence: Where IP Meets Market Strategy
Lagerman Subsidium offer affordable and comprehensive intellectual property and market analysis services tailored for your specific life science sector. With deep expertise in business development and intellectual property (IP), we go beyond traditional market analysis by integrating advanced patent database and market database analysis with cutting edge artificial intelligence tools. Our services provide insights into product positioning, partnering opportunities, and actionable strategic input to ensure your product avoids risks and thrives in a competitive market.
What Innovation Intelligence services do we offer?
  • Competitive Market Intelligence
    We deliver actionable insights into market trends, competitor activities, emerging technologies, and product pipelines. By combining market analysis with competitor IP strategies, we help your business identify opportunities, anticipate threats, and maintain a competitive advantage in your industry.
  • Continuous Innovation Surveillance
    We provide ongoing monitoring services to track competitor activities, technology advancements, and market dynamics. Through regular updates on patent filings, product launches, and pipeline developments, we ensure you stay ahead of industry shifts with timely market forecasts and competitor watch reports.
  • Innovation Roadmapping
    We identify future innovation opportunities by analyzing emerging technologies and white space gaps. Our strategic roadmap aligns your R&D efforts and IP portfolio with market demands, uncovering untapped areas for growth and technological advancement.
  • IP Valuations and Licensing Strategy
    We evaluate the quality and commercial value of intellectual property assets while developing possible licensing strategies. This service helps optimize your IP portfolio for monetization, including licensing opportunities, favorable partnerships, and well-structured negotiation terms.
  • IP Risk & Due Diligence Assessment
    We perform thorough evaluations of intellectual property portfolios during mergers, acquisitions, or partnerships. Our assessments highlight potential risks and opportunities, supporting informed decision-making in corporate transactions while reinforcing long-term IP strategy.
  • Freedom-To-Operate Assessments
    We conduct comprehensive evaluation of potential patent risks to ensure your product can be commercialized without infringing on existing intellectual property rights. This includes patent landscape analysis, detailed patent claim evaluations, infringement risk assessments, and strategic mitigation strategies such as design-around solutions and licensing opportunities.
Why Choose Us?
What sets us apart is our ability to combine business development insights with actionable intelligence. We serve as a flexible resource, delivering both customized, in-depth reports and ongoing monitoring of your competitors and market landscape. With deep expertise across biotechnology, pharmaceuticals, medical devices, diagnostics, digital health, and the broader life sciences sector, we bridge the gap between business strategy and intellectual property analysis. We help you make informed decisions to achieve your business goals.
Your main point of contact will be Alexander Lagerman, an IPR expert with over a decade of experience in the life science industry. With an educational background in Bioscience Business, Molecular Biology, and Corporate Economics, Alexander has collaborated with more than 50 life science projects across various sectors including drug development (antibodies, peptides, drug delivery systems), immunotherapies (vaccines, viral therapies), medical devices (dry-eye management systems, dental equipment), diagnostics (genetic testing, cardiovascular diagnostics, biomarker identification, PET tracers. imaging technologies) microfluidic devices (lab-on-a-chips, graphene-based biosensors, assays, microdroplets), lab tools & consumables (reagents & labels, disease models, 3D cell cultures, extracellular vesicle isolation), biologics production (cell line engineering, purification methodologies), CRO (ADME studies, immunogenicity assessments).
How to Contact Us?
Please feel free to contact us today for a consultation and discover how we can support your innovation intelligence.
Оur contacts:

© All Right Reserved. Lagerman Subsidium
Made on
Tilda